Literature DB >> 2648190

Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache.

M J Belgrade1, L J Ling, M B Schleevogt, M G Ettinger, E Ruiz.   

Abstract

We treated 64 emergency room patients with a primary vascular headache with dihydroergotamine (DHE), meperidine, or butorphanol. Post-treatment pain scores were lowest in the DHE group (p less than 0.01). Eight of 21 patients receiving DHE had greater than 90% reduction in pain compared with three of 19 patients receiving butorphanol and none of 22 receiving meperidine.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2648190     DOI： 10.1212/wnl.39.4.590

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  14 in total

Review 1.  Diagnosis and management of the primary headache disorders in the emergency department setting.

Authors:  Benjamin Wolkin Friedman; Brian Mitchell Grosberg
Journal:  Emerg Med Clin North Am       Date:  2009-02       Impact factor: 2.264

Review 2.  Acute treatment of migraines.

Authors:  Arnaldo N Da Silva; Stewart J Tepper
Journal:  CNS Drugs       Date:  2012-10-01       Impact factor: 5.749

Review 3.  Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine.

Authors:  Stephen D Silberstein; Shashidhar H Kori
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

4.  Metoclopramide for acute migraine: a dose-finding randomized clinical trial.

Authors:  Benjamin W Friedman; Laura Mulvey; David Esses; Clemencia Solorzano; Joseph Paternoster; Richard B Lipton; E John Gallagher
Journal:  Ann Emerg Med       Date:  2011-01-12       Impact factor: 5.721

5.  Prospective, randomised, double blind, controlled comparison of metoclopramide and pethidine in the emergency treatment of acute primary vascular and tension type headache episodes.

Authors:  M Cicek; O Karcioglu; I Parlak; V Ozturk; O Duman; M Serinken; M Guryay
Journal:  Emerg Med J       Date:  2004-05       Impact factor: 2.740

Review 6.  Intranasal medications for the treatment of migraine and cluster headache.

Authors:  Alan M Rapoport; Marcelo E Bigal; Stewart J Tepper; Fred D Sheftell
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 7.  Treatment of pediatric migraine in the emergency room.

Authors:  Amy A Gelfand; Peter J Goadsby
Journal:  Pediatr Neurol       Date:  2012-10       Impact factor: 3.372

Review 8.  Headache.

Authors:  N H Raskin
Journal:  West J Med       Date:  1994-09

9.  Intravenous administration of metoclopramide by 2 min bolus vs 15 min infusion: does it affect the improvement of headache while reducing the side effects?

Authors:  Ismet Parlak; Bulent Erdur; Mine Parlak; Ahmet Ergin; Ibrahim Turkcuer; Onder Tomruk; Cuneyt Ayrik; Nesrin Ergin
Journal:  Postgrad Med J       Date:  2007-10       Impact factor: 2.401

Review 10.  The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials.

Authors:  Benjamin W Friedman; Alok Kapoor; Matt S Friedman; Michael L Hochberg; Brian H Rowe
Journal:  Ann Emerg Med       Date:  2008-07-16       Impact factor: 5.721
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.